跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
IRINOCAN 100 CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ 5 ML
Approved
STANDARD
IRINOCAN 100 CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ 5 ML
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
18f7b77a96efa72f
Company
Unknown
Type
Standard
Approval Details
Approval Id
18f7b77a96efa72f
Drug Name
IRINOCAN 100 CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ 5 ML
Active Ingredients
Irinotecan 86.65 mg eqv to Irinotecan Hydrochloride Trihydrate
100 mg/vial
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
18f7b77a96efa72f
Type
Standard
Back to HSA Approvals
IRINOCAN 100 CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ 5 ML - HSA Drug Approval Details
